Aerovate Therapeutics
NASDAQ: AVTE
Healthcare
Biotechnology
Rank
#25504
Market Cap
77.68 M
Volume
29,370
Price
93.80
Change (%)
3400.00%
Country or region
United States
United States
Aerovate Therapeutics's latest marketcap:
77.68 M
As of April 29, 2025, Aerovate Therapeutics's market capitalization has reached $77.68 M. According to our data, Aerovate Therapeutics is the 25504th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 77.68 M |
| Revenue (ttm) | 0 |
| Net Income (ttm) | -48,960,000 |
| Shares Out | 828,142 |
| EPS (ttm) | -59.34 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | May 12, 2025 |
Market Cap Chart
Data Updated: April 29, 2025
Aerovate Therapeutics's yearly market capitalization.
Aerovate Therapeutics has seen its market value drop from $287.80 M to $80.29 M since 2021, representing a total decrease of 72.10% and an annual compound decline rate (CAGR) of 32.04%.
| Date | Market Cap | Change (%) |
|---|---|---|
| April 21, 2025 | $80.29 M | 4.93% |
| December 31, 2024 | $76.52 M | -87.78% |
| December 29, 2023 | $626.15 M | -13.15% |
| December 30, 2022 | $720.93 M | 150.5% |
| December 31, 2021 | $287.80 M |
Company Profile
Frequently Asked Questions
As of April 29, 2025, Aerovate Therapeutics (including the parent company, if applicable) has an estimated market capitalization of $77.68 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
Aerovate Therapeutics global market capitalization ranking is approximately 25504 as of April 29, 2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.
Stock Detail
| Country or region | United States |
| Founded | 2018 |
| IPO Date | June 30, 2021 |
| Employees | 30 |
| CEO | |
| Sector | Healthcare |
| Industry | Biotechnology |
| Address |
